VENUE CHANGE!
The NovAliX Conference will now take place at HILTON STRASBOURG - More info here.
***
Read the Testimonials of the 2015 Conference attendees now!
***
Accommodation - important notice
During the same week of June a session of the European Parliament will take place in Strasbourg, we therefore recommend you to book your accommodation well in advance!
|
Committee
Conference Chairman
| Dr J.-P. RENAUD (NovAliX & RiboStruct, Illkirch, France) |
Scientific Committee
| Dr J. BRYSON (Bristol-Myers-Squibb R&D, New York, United States) |
| Dr C.-W. CHUNG (GlaxoSmithKline, Stevenage, United Kingdom) |
| Prof. H. DANIELSON (Uppsala University, Uppsala, Sweden) |
| Dr U. EGNER (Bayer HealthCare, Berlin, Germany) |
| Dr M. HENNIG (leadXpro AG, Villigen, Switzerland) |
| Dr G. HOLDGATE (AstraZeneca, Macclesfield, United Kingdom) |
| Prof. R. HUBBARD (University of York & Vernalis, Cambridge, United Kingdom) |
| Prof. G. KLEBE (Philipps-University Marburg, Marburg, Germany) |
| Dr H. NAR (Boehringer Ingelheim, Biberach, Germany) |
| Dr J. OTTL (Novartis Institute of Biomedical Research, Basel, Switzerland) |
| Dr J.-P. RENAUD (NovAliX & RiboStruct, Illkirch, France) |
|
Organised by
Sponsored by
Media Partners
|
